Elixinol Wellness Ltd (ASX: EXL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Elixinol Wellness Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$4.14 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
413.99 million
Earnings per share
-0.003
Dividend per share
N/A
Year To Date Return
11.11%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Elixinol Wellness Ltd (ASX: EXL)
Latest News
Share Market News
ASX stock of the day: Elixinol Global (ASX:EXL) shares blaze new highs
Share Market News
Here's why ASX cannabis shares are falling today
Share Market News
Elixinol share price edges higher on half year earnings release
How to invest
Should you ever buy into an ASX IPO?
Share Fallers
Why Elixinol Global, National Storage, Qantas, & Vicinity shares are dropping lower
Share Gainers
Why this ASX cannabis share zoomed 9% higher today
Share Market News
Cannabis share Elixinol Global announces asset sales
Share Gainers
Why these 3 ASX cannabis shares are flying high in 2020
Share Fallers
Why cannabis company Elixinol Global is down 25% in just two days
52-Week Lows
Bank of Queensland and these ASX shares just sank to multi-year lows
Share Fallers
Why a2 Milk, Elixinol Global, Estia Health, & McMillan Shakespeare are dropping lower
Record Lows
Why the Elixinol Global share price crashed to a record low today
EXL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Elixinol Wellness Ltd
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.
EXL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 18 Feb 2026 | $0.01 | $0.00 | 0.00% | 163,041 | $0.01 | $0.01 | $0.01 |
| 17 Feb 2026 | $0.01 | $0.00 | 0.00% | 188,033 | $0.01 | $0.01 | $0.01 |
| 16 Feb 2026 | $0.01 | $0.00 | 0.00% | 64,537 | $0.01 | $0.01 | $0.01 |
| 13 Feb 2026 | $0.01 | $0.00 | 0.00% | 385 | $0.01 | $0.01 | $0.01 |
| 12 Feb 2026 | $0.01 | $0.00 | 0.00% | 409,588 | $0.01 | $0.01 | $0.01 |
| 11 Feb 2026 | $0.01 | $0.00 | 0.00% | 697,968 | $0.01 | $0.01 | $0.01 |
| 10 Feb 2026 | $0.01 | $0.00 | 0.00% | 10,467 | $0.01 | $0.01 | $0.01 |
| 09 Feb 2026 | $0.01 | $0.00 | 0.00% | 13,490 | $0.01 | $0.01 | $0.01 |
| 06 Feb 2026 | $0.01 | $0.00 | 0.00% | 205,172 | $0.01 | $0.01 | $0.01 |
| 05 Feb 2026 | $0.01 | $0.00 | 0.00% | 1,490 | $0.01 | $0.01 | $0.01 |
| 04 Feb 2026 | $0.01 | $0.00 | 0.00% | 50,043 | $0.01 | $0.01 | $0.01 |
| 03 Feb 2026 | $0.01 | $0.00 | 0.00% | 646 | $0.01 | $0.01 | $0.01 |
| 02 Feb 2026 | $0.01 | $0.00 | 0.00% | 43,584 | $0.01 | $0.01 | $0.01 |
| 30 Jan 2026 | $0.01 | $0.00 | 0.00% | 737,795 | $0.01 | $0.01 | $0.01 |
| 29 Jan 2026 | $0.01 | $0.00 | 0.00% | 7,424,343 | $0.01 | $0.01 | $0.01 |
| 28 Jan 2026 | $0.01 | $0.00 | 0.00% | 125,545 | $0.01 | $0.01 | $0.01 |
| 27 Jan 2026 | $0.01 | $0.00 | 0.00% | 13,351 | $0.01 | $0.01 | $0.01 |
| 23 Jan 2026 | $0.01 | $0.00 | 0.00% | 4,973,628 | $0.01 | $0.01 | $0.01 |
| 22 Jan 2026 | $0.01 | $0.00 | 0.00% | 2,501,998 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 30 Dec 2025 | Gavin Evans | Buy | 397,010 | $3,820 |
On-market trade.
|
| 27 Jun 2025 | Natalie Butler | Issued | 36,417 | $400 |
Conversion of securities.
|
| 27 Jun 2025 | Natalie Butler | Exercise | 36,417 | $400 |
Conversion of securities. 36,417 Performance Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Pauline Therese Gately | Non-Executive Director | Aug 2023 |
Ms Gately is a director who brings a commercial focus to strategy in funding, business development, and strategic transformation having led companies through IPO, business recalibration and mergers and acquisitions. Her Board contributions are also underpinned by senior roles in international investment banking across the Asia Pacific region. She is Chair of the Risk Committee.
|
| Ms Natalie Butler | Head of MarketingExecutive Director | Mar 2024 |
Ms Butler over a decade of strategic marketing leadership to the table, Natalie has a proven history of growth and innovation on both local and global brands. Having worked closely with the Sustainable Nutrition Group marketing and product teams over the past year, she is uniquely positioned to spearhead future growth opportunities for the Group. As General Manager of Tom Organic, Natalie steered the company to success and direct major global initiatives with renowned brands within the L'Oreal Group.
|
| Mr Gavin Evans | Non-Executive ChairmanNon-Executive Director | Dec 2025 |
Mr Gavin has experience in building profitable, vertically integrated food and wellness
businesses, having founded Openway Food Co and led multiple growth platforms..He has recently been supporting the Company as a Strategic Adviser and brings deep capability across execution, M&A, brand building and supply-chain optimisation, along with strong industry relationships that will support Elixinol's continued transformation and path to profitability. |
| Ms Melanie Jaye Leydin | Company Secretary | Jul 2024 |
-
|
| Melanie Jaye Leydin | Company Secretary |
-
|
|
| Josephine Lorenz | Group Chief Financial Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Freedom Trader Pty Ltd | 14,692,194 | 6.65% |
| Mr Stuart Reseck & Mrs Nicole Deanne Reseck (Reseck Super Fund A/C) | 13,333,334 | 6.04% |
| Cutter Super Pty Ltd (Cutter Sf A/C) | 12,500,000 | 5.66% |
| HSBC Custody Nominees (Australia) Limited | 10,047,366 | 4.55% |
| Cg Nominees (Australia) Pty Ltd | 9,574,074 | 4.34% |
| UBS Nominees Pty Ltd | 7,838,694 | 3.55% |
| 10 Bolivianos Pty Ltd | 6,011,427 | 2.72% |
| G & A Eshuys Superannuation Pty Ltd (G & A Eshuys S/F A/C) | 4,318,665 | 1.96% |
| Gidgell Pty Ltd (The Jay-Em A/C) | 4,256,887 | 1.93% |
| BNP Paribas Noms Pty Ltd | 4,228,987 | 1.92% |
| Rosedale Super Pty Ltd (Rosedale Super Fund A/C) | 3,343,022 | 1.51% |
| Citicorp Nominees Pty Limited | 2,386,228 | 1.08% |
| Jasforce Pty Ltd (Alex Waislitz Retire A/C) | 2,306,551 | 1.04% |
| Ms Pauline Therese Gately | 2,296,671 | 1.04% |
| Capital Accretion Pty Ltd (The Fortified Value A/C) | 2,233,798 | 1.01% |
| Interdale Pty Ltd (Maple Super A/C) | 2,157,888 | 0.98% |
| Raw With Life Pty Ltd (Benhaim Trading A/C) | 2,111,611 | 0.96% |
| Mr David John Fenlon | 1,563,381 | 0.71% |
| Mr Kieran John O'Brien | 1,562,500 | 0.71% |
| A&N Mcintosh Holdings Pty Ltd (Tiger Investment A/C) | 1,551,196 | 0.70% |
